BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18678353)

  • 21. Preliminary biological evaluation of novel (99m)Tc-Cys-annexin A5 as a apoptosis imaging agent.
    Lu C; Jiang Q; Hu M; Tan C; Ji Y; Yu H; Hua Z
    Molecules; 2013 Jun; 18(6):6908-18. PubMed ID: 23752473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabeling and Quantitative In Vivo SPECT/CT Imaging Study of Liposomes Using the Novel Iminothiolane-
    Varga Z; Szigyártó IC; Gyurkó I; Dóczi R; Horváth I; Máthé D; Szigeti K
    Contrast Media Mol Imaging; 2017; 2017():4693417. PubMed ID: 29097923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.
    Teodoro R; Faintuch BL; Núñez EG; Queiróz RG
    Nucl Med Biol; 2011 Jan; 38(1):113-20. PubMed ID: 21220134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.
    Surfraz MB; King R; Mather SJ; Biagini S; Blower PJ
    J Inorg Biochem; 2009 Jul; 103(7):971-7. PubMed ID: 19447500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals.
    Koźmiński P; Gniazdowska E
    Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ApoCorrect assay: a novel, rapid method to determine the biological functionality of radiolabeled and fluorescent Annexin A5.
    Boersma HH; Stolk LM; Kenis H; Deckers NM; Vanderheyden JL; Hofstra L; Heidendal GA; Reutelingsperger CP
    Anal Biochem; 2004 Apr; 327(1):126-34. PubMed ID: 15033520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodistribution of 99mTc-HYNIC-lactadherin in mice--a potential tracer for visualizing apoptosis in vivo.
    Falborg L; Waehrens LN; Alsner J; Bluhme H; Frøkiaer J; Heegaard CW; Horsman MR; Rasmussen JT; Rehling M
    Scand J Clin Lab Invest; 2010 Apr; 70(3):209-16. PubMed ID: 20377487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.
    Greenland WE; Howland K; Hardy J; Fogelman I; Blower PJ
    J Med Chem; 2003 Apr; 46(9):1751-7. PubMed ID: 12699393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct 99m Tc labeling of Herceptin (trastuzumab) by 99m Tc(I) tricarbonyl ion.
    Chen WJ; Yen CL; Lo ST; Chen KT; Lo JM
    Appl Radiat Isot; 2008 Mar; 66(3):340-5. PubMed ID: 17996452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
    Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
    Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple and efficient method for radiolabeling of preformed liposomes.
    Suresh M; Cao Y
    J Pharm Pharm Sci; 1998; 1(1):31-7. PubMed ID: 10942970
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Xu X; Zhang J; Hu S; He S; Bao X; Ma G; Luo J; Cheng J; Zhang Y
    Nucl Med Biol; 2017 May; 48():69-75. PubMed ID: 28273495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and evaluation of a novel (99m)tc-labeled annexin A5 for early detection of response to chemotherapy.
    Ogawa K; Ohtsuki K; Shibata T; Aoki M; Nakayama M; Kitamura Y; Ono M; Ueda M; Doue T; Onoguchi M; Shiba K; Odani A
    PLoS One; 2013; 8(12):e81191. PubMed ID: 24324676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and comparative evaluation of
    Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Banerjee S
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):68-76. PubMed ID: 29139598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucosamine conjugates bearing N,N,O-donors: potential imaging agents utilizing the [M(CO)3]+ core (M = Re, Tc).
    Bowen ML; Lim NC; Ewart CB; Misri R; Ferreira CL; Häfeli U; Adam MJ; Orvig C
    Dalton Trans; 2009 Nov; (42):9216-27. PubMed ID: 20449199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
    Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
    Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotaxis, viability, and labeling stability of leukocytes labeled with (99m)Tc-exametazime stabilized with methylene blue.
    Roca M; Iglesias F; García V; Armero F; Díaz MC
    J Nucl Med; 2001 Mar; 42(3):505-8. PubMed ID: 11337530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy.
    Rottey S; Slegers G; Van Belle S; Goethals I; Van de Wiele C
    J Nucl Med; 2006 Nov; 47(11):1813-8. PubMed ID: 17079815
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
    J Labelled Comp Radiopharm; 2017 Jul; 60(9):431-438. PubMed ID: 28545160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Labelling of the anti-III-neurotubulin monoclonal antibody by 99mTc and its binding to responsible antigen.
    Slapnicková K; Kolárová P; Kynclová K
    Nucl Med Rev Cent East Eur; 2007; 10(1):1-5. PubMed ID: 17694493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.